Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mefunidone ameliorates diabetic kidney disease in STZ and db/db mice
Yupeng Jiang, Feifei Xie, Xin Lv, et al.
The FASEB Journal (2020) Vol. 35, Iss. 1
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Role of Ferroptosis in Regulating the Epithelial–Mesenchymal Transition in Pulmonary Fibrosis
Hong Ling, Hong Xiao, Ting Luo, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 163-163
Open Access | Times Cited: 22
Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis
Jian Jia, Ruizhi Tan, Linghui Xu, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112303-112303
Closed Access | Times Cited: 9
Role of TGF-β1/Smad3 signalling pathway in renal tubulointerstitial fibrosis and renal damage in elderly rats with isolated systolic hypertension induced by increased pulse pressure
Lu Li, Guiling Xia, Lei Lei, et al.
Acta Cardiologica (2025), pp. 1-13
Closed Access | Times Cited: 1
Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice
Jiajia Wu, Yan Chen, Huinan Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 18
Exercise training ameliorates early diabetic kidney injury by regulating the H2S/SIRT1/p53 pathway
Lu Yang, Dongxia Li, Buqing Cao, et al.
The FASEB Journal (2021) Vol. 35, Iss. 9
Closed Access | Times Cited: 33
Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3‐Dependent Podocyte‐Mesenchymal Transition
Qiong Hu, Honglian Wang, Jian Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 32
Open Access | Times Cited: 13
AGO2 Protects Against Diabetic Cardiomyopathy by Activating Mitochondrial Gene Translation
Jiabing Zhan, Kunying Jin, Rong Xie, et al.
Circulation (2023) Vol. 149, Iss. 14, pp. 1102-1120
Closed Access | Times Cited: 13
Mefunidone alleviates silica-induced inflammation and fibrosis by inhibiting the TLR4-NF-κB/MAPK pathway and attenuating pyroptosis in murine macrophages
Lingzhi Long, Xiao‐Qing Dai, Tingting Yao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117216-117216
Closed Access | Times Cited: 5
The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease
Yiqi Yang, Haibo Tan, Xiaoyu Zhang, et al.
Journal of Ethnopharmacology (2022) Vol. 292, pp. 115165-115165
Closed Access | Times Cited: 19
Advances and perspective on animal models and hydrogel biomaterials for diabetic wound healing.
Yiqiang Hu, Yuan Xiong, Ranyang Tao, et al.
PubMed (2022) Vol. 3, Iss. 3, pp. 188-200
Closed Access | Times Cited: 19
A kidney-targeted chitosan-melanin nanoplatform for alleviating diabetic nephropathy through modulation of blood glucose and oxidative stress
Jinghua Sun, Juanjuan Han, Jie Dong, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130663-130663
Closed Access | Times Cited: 4
Pathological mechanism of immune disorders in diabetic kidney disease and intervention strategies
Tong Zhou, Yilin Fang, Tiantian Tian, et al.
World Journal of Diabetes (2024) Vol. 15, Iss. 6, pp. 1111-1121
Open Access | Times Cited: 4
Seabuckthorn polysaccharide alleviates renal fibrosis in a mouse model of diabetic nephropathy via p311/TGFβ1/Fstl1 signaling pathway
Qian Huang, Zilu Shi, Dandan Zheng, et al.
Pathology - Research and Practice (2025) Vol. 267, pp. 155808-155808
Closed Access
Translation Animal Models of Diabetic Kidney Disease: Biochemical and Histological Phenotypes, Advantages and Limitations
Wenting Luo, Shiyun Tang, Xiang Xiao, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 1297-1321
Open Access | Times Cited: 10
Mefunidone ameliorates acute liver failure in mice by inhibiting MKK4-JNK pathway
Yanqiu Zhang, Xin He, Lei Gu, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116267-116267
Closed Access | Times Cited: 3
Dihydromyricetin ameliorates diabetic renal fibrosis via regulating SphK1 to suppress the activation of NF-κB pathway
Min Wen, Xiaohong Sun, Linjie Pan, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176799-176799
Closed Access | Times Cited: 3
Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
Yuanyuan Han, Mao Jiang, Rongling He, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 19
Unraveling the superiority of (−)‐gallocatechin gallate to (−)‐epigallocatechin‐3‐gallate in protection of diabetic nephropathy of db/db mice
Xin Xiao, Feng Ling, Huijun Cheng, et al.
Food Frontiers (2024) Vol. 5, Iss. 2, pp. 771-788
Open Access | Times Cited: 2
A phase I, randomized study to evaluate the safety, tolerability, and pharmacokinetics of mefunidone in healthy subjects
Mai Han, Bishan Huo, Gaoyun Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
The role of JNK signaling pathway in organ fibrosis
Zhouhui Yao, Yandan Lu, Pingping Wang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
PPARβ/δ Agonist Alleviates Diabetic Osteoporosis via Regulating M1/M2 Macrophage Polarization
Miao Chen, Weimin Lin, Rui Ye, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 17
Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms
Kai Liu, Xing Zhao, Xue Qi, et al.
European Journal of Medicinal Chemistry (2021) Vol. 218, pp. 113388-113388
Open Access | Times Cited: 16
Protective effects of mefunidone on ischemia-reperfusion injury/Folic acid-induced acute kidney injury
Jiajia Li, Yupeng Jiang, Qin Dai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Fluorofenidone enhances cisplatin efficacy in non-small cell lung cancer: a novel approach to inhibiting cancer progression
Shunjun Wang, Guowei Liu, Laishun Yu, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 11, pp. 3175-3188
Open Access | Times Cited: 2
Is type 2 diabetes mellitus another intercellular junction-related disorder?
Carla Beatriz Collares‐Buzato, Carolina Prado de França Carvalho
Experimental Biology and Medicine (2022) Vol. 247, Iss. 9, pp. 743-755
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top